SAM
NTUS

Silvercrest Asset Management’s Natus Medical Inc NTUS Stock Holding History

Silvercrest Asset Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,124,256
Closed -$26M – 779
2020
Q1 		$26M Sell
1,124,256
-244,466
-18% -$7.11M 0.28% 112
2019
Q4 		$45.2M Sell
1,368,722
-374,129
-21% -$12M 0.35% 100
2019
Q3 		$55.5M Buy
1,742,851
+129,212
+8% +$3.77M 0.46% 81
2019
Q2 		$41.5M Buy
1,613,639
+2,362
+0.1% +$60.2K 0.39% 109
2019
Q1 		$40.9M Sell
1,611,277
-62,669
-4% -$1.87M 0.4% 102
2018
Q4 		$57M Sell
1,673,946
-101,380
-6% -$3.3M 0.63% 61
2018
Q3 		$63.3M Buy
1,775,326
+3,524
+0.2% +$124K 0.57% 68
2018
Q2 		$61.1M Buy
1,771,802
+74,071
+4% +$2.6M 0.57% 68
2018
Q1 		$57.1M Sell
1,697,731
-9,409
-0.6% -$298K 0.56% 67
2017
Q4 		$65.2M Buy
1,707,140
+237,006
+16% +$9.46M 0.61% 60
2017
Q3 		$55.1M Buy
+1,470,134
New +$51.9M 0.55% 71

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Silvercrest Asset Management's NTUS Position: Q2 2020 in Review

Silvercrest Asset Management sold out of Natus Medical Inc (NTUS) in Q2 2020, closing a stake of 1,124,256 shares — an estimated $26M sold.

Silvercrest Asset Management first reported a position in NTUS in Q3 2017 and held it in 11 quarters. The position peaked at $65.2M in Q4 2017. 172 funds tracked by Wall St. Rank hold NTUS as of Q2 2020.

  • Silvercrest Asset Management reported no remaining Natus Medical Inc position as of Q2 2020 after selling out during the quarter.
  • Silvercrest Asset Management sold 1,124,256 Natus Medical Inc shares in Q2 2020, an estimated $26M.
  • Silvercrest Asset Management first reported a position in Natus Medical Inc in Q3 2017 and held it in 11 quarters.
  • Silvercrest Asset Management's Natus Medical Inc position peaked at $65.2M in Q4 2017.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2020.

Based on Silvercrest Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.